Loading…
Alphatec Holdings, Inc. is projected to rise to $10.39 by 2027, a +8% move from its current price of $9.58. ATEC is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $9.30 | $9.58 | $9.87 | +0.04% |
| Jul 14 | $9.19 | $9.59 | $10.00 | +0.07% |
| Jul 15 | $9.11 | $9.59 | $10.10 | +0.11% |
| Jul 16 | $9.04 | $9.59 | $10.18 | +0.15% |
| Jul 17 | $8.98 | $9.60 | $10.26 | +0.19% |
| Jul 18 | $8.93 | $9.60 | $10.33 | +0.22% |
| Jul 19 | $8.88 | $9.61 | $10.39 | +0.26% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $8.88 | $9.61 | $10.39 | +0.26% |
| Week 2 | $8.62 | $9.63 | $10.76 | +0.52% |
| Week 3 | $8.43 | $9.66 | $11.07 | +0.79% |
| Week 4 | $8.27 | $9.68 | $11.33 | +1.05% |
| Week 5 | $8.14 | $9.71 | $11.57 | +1.32% |
| Week 6 | $8.03 | $9.73 | $11.80 | +1.58% |
| Week 7 | $7.92 | $9.76 | $12.01 | +1.85% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Alphatec Holdings, Inc. is a medical technology company that designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants, instruments, imaging equipment, and spare parts.
It offers the Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissue; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications.
The company sells its products through a network of independent sales agents and direct sales representatives. The company was founded in 1990 and is headquartered in Carlsbad, California.
Alphatec Holdings, Inc. (ATEC) is a healthcare stock currently trading at $9.30. The company has a market capitalization of $1.43B and is ranked 2279. The current price aligns with a neutral near-term baseline, as reflected in the 2026 forecast where min $6.99, avg $9.30, max $11.96 and ROI 0% indicate a neutral stance.
A major floor 29.2% below — a decisive break under it would weaken the trend.
The nearest floor, 21.9% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 36.2% above — clearing it would confirm fresh momentum.
Key ATEC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ATEC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $9.40 | Buy | $9.39 | Buy |
| MA 10 | $9.22 | Buy | $9.20 | Buy |
| MA 20 | $8.85 | Buy | $8.94 | Buy |
| MA 50 | $8.45 | Buy | $9.10 | Buy |
| MA 100 | $10.22 | Sell | $10.40 | Sell |
| MA 200 | $13.96 | Sell | $11.93 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 61.68 | Neutral |
| Stoch RSI (14) | 73.19 | Neutral |
| CCI (20) | 123.58 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.09 | Buy |
| ROC (12) | 12.71 | Buy |
| Bollinger %B (20,2) | 0.90 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.35 | Buy |
| Awesome (5,34) | 0.93 | Buy |
| Ultimate (7,14,28) | 76.36 | Sell |
| Momentum (10) | 0.75 | Buy |
| Aroon Osc (25) | 100.00 | Buy |
| Hull MA (9) | 9.55 | Buy |
| ADX (14) | 15.32 | Neutral |
| ATR (14) | 0.24 | Info |
The 30-day technical picture shows a bullish undertone overall, with RSI14 at 60. The near-term moving averages sit at $8.74 for the SMA50 and $14.27 for the SMA200, framing a balance between support and momentum. Near-term support is identified at $7.48 and resistance at $8.83, with the 30-day price range between $7.71 and $11.22.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $6.99 | $9.58 | $12.20 | 0% | Neutral | |
| $8.20 | $10.39 | $13.97 | +8% | Neutral | |
| $8.29 | $10.83 | $15.14 | +13% | Neutral | |
| $9.02 | $12.09 | $17.44 | +26% | Bullish | |
| $9.74 | $13.35 | $19.77 | +39% | Bullish | |
| $11.72 | $16.39 | $24.83 | +71% | Bullish | |
| $13.39 | $19.09 | $29.51 | +99% | Bullish | |
| $13.63 | $19.79 | $31.15 | +107% | Bullish | |
| $13.74 | $20.30 | $32.51 | +112% | Bullish | |
| $13.65 | $20.50 | $33.34 | +114% | Bullish | |
| $21.39 | $34.62 | $60.13 | +261% | Bullish | |
| $32.02 | $59.08 | $112.83 | +517% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $6.99 | $9.58 | $11.43 | +0.00% |
| August 2026 | $8.11 | $9.59 | $11.67 | +0.11% |
| September 2026 | $8.31 | $9.91 | $12.20 | +3.35% |
| October 2026 | $8.32 | $9.99 | $12.42 | +0.75% |
| November 2026 | $8.02 | $9.68 | $12.14 | -3.07% |
| December 2026 | $7.96 | $9.65 | $12.20 | -0.27% |
Click any year to see its month-by-month ATEC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The ATEC price prediction for 2026 points to an average of $9.58 (low $6.99, high $12.20) — a potential gain of 0% on today's $9.58. Price action looks broadly range-bound.
In 2027, ATEC is projected to trade between $8.20 and $13.97, averaging $10.39 — a potential gain of +8% from today's $9.58. That is up +8% on the projected 2026 average. A consolidation phase looks the most probable path here.
Alphatec Holdings, Inc.'s 2028 outlook centres on $10.83, within a $8.29 to $15.14 range. That is up +4% on the projected 2027 average. That marks a +13% change versus current levels. Price action looks broadly range-bound.
By 2029, ATEC could reach as high as $17.44, with a base case around $12.09 and support toward $9.02 — roughly +26% from $9.58. Buyers look set to stay in control over this stretch.
Expect ATEC to range from $9.74 to $19.77 through 2030. The $13.35 average target implies a +39% move from current prices. That is up +10% on the projected 2029 average. Momentum favours further upside here.
The ATEC price prediction for 2031 points to an average of $16.39 (low $11.72, high $24.83) — a potential gain of +71% on today's $9.58. Buyers look set to stay in control over this stretch.
In 2032, ATEC is projected to trade between $13.39 and $29.51, averaging $19.09 — a potential gain of +99% from today's $9.58. That is up +16% on the projected 2031 average. Momentum favours further upside here.
Alphatec Holdings, Inc.'s 2033 outlook centres on $19.79, within a $13.63 to $31.15 range. That is up +4% on the projected 2032 average. That marks a +107% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, ATEC could reach as high as $32.51, with a base case around $20.30 and support toward $13.74 — roughly +112% from $9.58. Momentum favours further upside here.
Expect ATEC to range from $13.65 to $33.34 through 2035. The $20.50 average target implies a +114% move from current prices. That is up +1% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The ATEC price prediction for 2040 points to an average of $34.62 (low $21.39, high $60.13) — a potential gain of +261% on today's $9.58. Momentum favours further upside here.
In 2050, ATEC is projected to trade between $32.02 and $112.83, averaging $59.08 — a potential gain of +517% from today's $9.58. That is up +71% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in ATEC today (≈ 104.384134 ATEC) could be worth
$6,167.23
+$5,167.23 (+517%) by 2050 · US Dollar
Based on the average projected ATEC price of $59.08 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ATECwould be worth at today's price.
$1,000 invested in ATEC on Jul 10, 2025 (≈ 86.355786 ATEC) would be worth
$827.29
-$172.71 (-17.3%) today · 0.83× · US Dollar
Based on a ATEC entry price of $11.58 vs. today's $9.58.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $8.92 | $1,073.99 | +7.4% |
| 1 month ago | $8.13 | $1,178.35 | +17.8% |
| 3 months ago | $10.9 | $878.9 | -12.1% |
| 6 months ago | $17.59 | $544.63 | -45.5% |
| 1 year ago | $11.58 | $827.29 | -17.3% |
| All time (5.0y) ago | $15.08 | $635.28 | -36.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ATEC forecast.
Our base-case forecast reaches $19.00 around 2032.
Implied market cap at $19.00: $2.92B
Looking further out, the annual forecast points to a rising average price from 2026 through 2050. The 2026 average price is $9.30, with subsequent years showing higher levels, including 2030 at $12.46 and 2040 at $30.99, and reaching 2050 at $52.98. The forecast implies rising ROIs of 34% in 2030, 233.2% by 2040, and 469.7% by 2050, with bullish sentiment continuing through 2031–2050.
Yearly midpoints also progress through 2031 ($15.11) and 2032 ($17.94), continuing to higher levels in 2033 ($17.98), 2034 ($18.39), and 2035 ($19.29). These projections carry the caveat that they are estimates, not guarantees, and come with inherent uncertainty and risks.
Tap a question to reveal the answer.
2030 avg $12.46; min $9.16; max $18.29; ROI 34%; sentiment BULLISH.
The forecast shows the average price rising from 2026 avg $9.30 to 2050 avg $52.98 with ROIs up to 469.7%. Notably, 2026 forecasts are neutral with ROI 0% before stronger upside from 2027 onward, with 2029 ROI 24.7% and subsequent years showing higher ROIs in a bullish trajectory.
The max forecast by 2050 is $99.50, which is just short of $100, with a 469.7% ROI.
The 30-day range is $7.71 to $11.22.
Current price $9.30; Market cap $1.43B; Rank 2279.
Alphatec Holdings, Inc. Community Discussion
0Share your Alphatec Holdings, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.